Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Post by garage64on Jun 16, 2014 9:12am

149 Views

Post# 22662558

LE TITRE DEVRAIENT ETRE A PLUS DE 0.12

LE TITRE EST SOUS- EVALUÉES, DANS LES PROCHAINS JOURS, LES RÉSULTATS DE FORAGE QUI ONT L'AIRE TRES CONCLUANT. LE TITRE VA GRIMPER A 0.15 A 0.20 D'ICI LA FIN DU MOIS. JE NE COMPRENDS PAS LES ACHETEURS, ILS ONT UN GROS POTENTIELS ENTRE LES MAINS.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week